Xiao-Lin Niu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiao-Lin Niu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Jin Wei
Xi’an Jiaotong University School of Medicine
2 shared publicationsCong Lei
Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China
1 shared publicationDeng-Feng Gao
Department of Cardiology, The Second Affiliated Hospital, Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi 710004, PR China
1 shared publicationGuang-Hua Hao
Department of Cardiology, The Second Affiliated Hospital, Xi’an Jiaotong University School of Medicine, Xi’an, Shaanxi 710004, PR China
1 shared publication- Nanping Wang
Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, China
1 shared publication Ning Ning
Department of Cardiology, The Second Affiliated Hospital, Xi’an Jiaotong University School of Medicine, Xi’an, Shaanxi 710004, PR China
1 shared publication
Latest Publications
- 24 June 2010
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 33 (2) , 183-188
Is selenium deficiency really the cause of Keshan disease?
Keshan disease (KD) is a dilated cardiomyopathy closely related with a diet deficient in the mineral selenium. It is named for the northeastern Chinese county Keshan, where the disease prevalence is high because of selenium-deficient soil. KD is a gene–environment interaction disease. Here, we used stepwise multiple regression analysis to analyze the risk factors of the disease and the main clinical features in 71 KD patients and 290 controls. The variables analyzed included age, sex, family history of KD, blood selenium level, glutathione peroxidase-1 (GPx-1) activity, variance at codon198 in GPx-1 gene, residence in an endemic area, abnormal electrocardiography (ECG) findings, and cardiothoracic (CT) ratio. The main risk factors found were low GPx-1 activity, family history of KD and living in an endemic area. The main clinical features were increased cardiac load on ECG and increased CT ratio and Tei index. Public health and clinical prevention efforts could focus on increasing GPx-1 activity to address KD. Is selenium deficiency really the certain cause of KD? This is not at all a settled question. And further study is promptly required to investigate the etiology of KD.
- 24 June 2010
- Published by Springer Nature in Environmental Geochemistry and Health
- Vol. 33 (2) , 183-188
Is selenium deficiency really the cause of Keshan disease?
Keshan disease (KD) is a dilated cardiomyopathy closely related with a diet deficient in the mineral selenium. It is named for the northeastern Chinese county Keshan, where the disease prevalence is high because of selenium-deficient soil. KD is a gene–environment interaction disease. Here, we used stepwise multiple regression analysis to analyze the risk factors of the disease and the main clinical features in 71 KD patients and 290 controls. The variables analyzed included age, sex, family history of KD, blood selenium level, glutathione peroxidase-1 (GPx-1) activity, variance at codon198 in GPx-1 gene, residence in an endemic area, abnormal electrocardiography (ECG) findings, and cardiothoracic (CT) ratio. The main risk factors found were low GPx-1 activity, family history of KD and living in an endemic area. The main clinical features were increased cardiac load on ECG and increased CT ratio and Tei index. Public health and clinical prevention efforts could focus on increasing GPx-1 activity to address KD. Is selenium deficiency really the certain cause of KD? This is not at all a settled question. And further study is promptly required to investigate the etiology of KD.
- 1 January 2007
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (2) , 185-197
Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells––Role of PPAR-γ in vascular fibrosis
- 1 January 2007
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (2) , 185-197
Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells––Role of PPAR-γ in vascular fibrosis